Importer of Controlled Substances Application: Mylan Pharmaceuticals Inc., 8220 [2021-02315]

Download as PDF 8220 Federal Register / Vol. 86, No. 22 / Thursday, February 4, 2021 / Notices Authority: Section 2 of the Paperwork Reduction Act of 1995, 44 U.S.C. 3507. Colette Pollard, Department Management Reports Management Officer, Office of the Chief Information Officer. Controlled substance Drug code Schedule To submit comments: Send them to: Remifentanil ...................... 9739 II By mail ......... Assistant Attorney General, U.S. DOJ—ENRD, P.O. Box 7611, Washington, D.C. 20044–7611. The company plans to import the above-controlled substance as the Federal Drug Administration-approved drug product in finished dosage form for commercial distribution to its customers. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). [FR Doc. 2021–02256 Filed 2–3–21; 8:45 am] BILLING CODE 4210–67–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–773] DEPARTMENT OF JUSTICE During the public comment period, the proposed consent decree may be examined and downloaded at this Justice Department website: https:// www.justice.gov/enrd/consent-decrees. We will provide a paper copy of the proposed consent decree upon written request and payment of reproduction costs. Please mail your request and payment to: Consent Decree Library, U.S. DOJ—ENRD, P.O. Box 7611, Washington, DC 20044–7611. Please enclose a check or money order for $8.50 (25 cents per page reproduction cost) payable to the United States Treasury. Notice of Lodging of Proposed Consent Decree Under the Clean Air Act (‘‘CAA’’) Jeffrey Sands, Assistant Section Chief, Environmental Enforcement Section, Environment and Natural Resources Division. William T. McDermott, Assistant Administrator. Importer of Controlled Substances Application: Mylan Pharmaceuticals Inc. [FR Doc. 2021–02315 Filed 2–3–21; 8:45 am] BILLING CODE P Drug Enforcement Administration, Justice. AGENCY: ACTION: Notice of application. Mylan Pharmaceuticals Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. SUMMARY: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 8, 2021. Such persons may also file a written request for a hearing on the application on or before March 8, 2021. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.34(a), this is notice that on December 18, 2020, Mylan Pharmaceuticals Inc., 2898 Manufacturers Road, Greensboro, North Carolina 27406–4600, applied to be registered as an importer of the following basic class(es) of controlled substance(s): jbell on DSKJLSW7X2PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 17:13 Feb 03, 2021 Jkt 253001 On January 29, 2021, the Department of Justice lodged a proposed consent decree with the United States District Court for the District of Utah in the lawsuit entitled United States v. Stericycle, Inc., Civil Action No. 1:21– cv–00012–JNP. The United States filed this lawsuit under the Clean Air Act alleging violations of NOx emission limits at Stericycle, Inc.’s medical waste incinerator in North Salt Lake, Utah (an ozone nonattainment area) and other related violations. The proposed consent decree will require Stericycle to pay a $600,000 civil penalty and conduct a supplemental environmental project to replace 15–20 pre-2006 diesel school buses with low emitting models at an estimated cost of $2,000,000. The publication of this notice opens a period for public comment on the proposed consent decree. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and should refer to United States v. Stericycle, Inc., D.J. Ref. No. 90–5–2–1–12057. All comments must be submitted no later than thirty (30) days after the publication date of this notice. Comments may be submitted either by email or by mail: To submit comments: Send them to: By email ....... pubcomment-ees.enrd@ usdoj.gov. PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 [FR Doc. 2021–02353 Filed 2–3–21; 8:45 am] BILLING CODE 4410–15–P DEPARTMENT OF LABOR Agency Information Collection Activities; Submission for OMB Review; Comment Request; Alternative Method of Compliance for Certain Simplified Employee Pensions Notice of availability; request for comments. ACTION: The Department of Labor (DOL) is submitting this EBSAsponsored information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (PRA). Public comments on the ICR are invited. DATES: The OMB will consider all written comments that agency receives on or before March 8, 2021. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. Comments are invited on: (1) Whether the collection of information is necessary for the proper performance of the functions of the Department, SUMMARY: E:\FR\FM\04FEN1.SGM 04FEN1

Agencies

[Federal Register Volume 86, Number 22 (Thursday, February 4, 2021)]
[Notices]
[Page 8220]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02315]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-773]


Importer of Controlled Substances Application: Mylan 
Pharmaceuticals Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Mylan Pharmaceuticals Inc. has applied to be registered as an 
importer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before March 8, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before March 8, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on December 18, 2020, Mylan Pharmaceuticals Inc., 2898 
Manufacturers Road, Greensboro, North Carolina 27406-4600, applied to 
be registered as an importer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
                                          Drug
          Controlled substance            code           Schedule
------------------------------------------------------------------------
Remifentanil...........................   9739   II
------------------------------------------------------------------------

    The company plans to import the above-controlled substance as the 
Federal Drug Administration-approved drug product in finished dosage 
form for commercial distribution to its customers. Approval of permit 
applications will occur only when the registrant's business activity is 
consistent with what is authorized under 21 U.S.C. 952(a)(2).

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-02315 Filed 2-3-21; 8:45 am]
BILLING CODE P